Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 13 Gastrointestinal 9 Thoracic 7 CNS 6 Breast 3 Other hematologic neoplasm 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Lymphoid 1 Gynecologic 1

Conditions

Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Temozolomide 63 Cyclophosphamide 55 Radiotherapy 53 Bevacizumab 50 Doxorubicin 48 Ifosfamide 33 pazopanib 28 fludarabine phosphate 28 Etoposide 27 Radiation 24 Gemcitabine 24 pembrolizumab 23 Sirolimus 23 Sunitinib 22 Filgrastim 22 Irinotecan 21 Whole-Body Irradiation 20 Peripheral Blood Stem Cell Transplantation 20 Mycophenolic Acid 20 Imatinib Mesylate 20 Vincristine 19 Magnetic Resonance Spectroscopy 18 Sorafenib 16 Methotrexate 16 Busulfan 16 Melphalan 15 Carboplatin 15 Docetaxel 14 Cyclosporine 14 temsirolimus 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × binimetinib × Sarcoma × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡